Progestogen only contraception in women with congenital heart disease.

Francesc Baró-MarinéAntonia Pijuan-DomènechMaria Del Mar GoyaElena Suárez-EdoBerta Miranda-BarrioLaura Dos-SubiràMaria Luisa PancorboIgnacio Ferreira-GonzalezElena Carreras-Moratonas

Published in: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology (2024)

Because of their safety and efficacy, IUD-IPs and SI-IPs should be considered as first-line contraception in patients with CHD.

Keyphrases

polycystic ovary syndrome
pregnancy outcomes
room temperature
cervical cancer screening
insulin resistance
metabolic syndrome